Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pharmacology & Therapeutics|January 22, 2018
Combining chemotherapy with PD-1 blockade in NSCLCMatthen Mathew, Thomas Enzler, Catherine A Shu, et al.
Cancers|October 3, 2020
Extracellular Vesicles as Biomarkers in Cancer ImmunotherapyMatthen Mathew, Mariam Zade, Nadia Mezghani, et al.
The Journal of Biological Chemistry|October 19, 2006
Myomaxin is a novel transcriptional target of MEF2A that encodes a Xin-related alpha-actinin-interacting proteinHsuan-Ting Huang, Ondra M Brand, Matthen Mathew, et al.
Cancer Immunology, Immunotherapy : CII|February 13, 2024
INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumorsJohn F Hilton, Patrick A Ott, Aaron R Hansen, et al.
Lung Cancer (Amsterdam, Netherlands)|July 4, 2020
Characteristics and outcomes of lung cancer in solid organ transplant recipientsLanyi Nora Chen, John Spivack, Thu Cao, et al.
Circulation Research|January 23, 2010
Modulation of angiotensin II-mediated cardiac remodeling by the MEF2A target gene Xirp2Sarah A McCalmon, Danielle M Desjardins, Saad Ahmad, et al.
Cell Reports. Medicine|December 13, 2022
Single-cell RNA sequencing reveals distinct T cell populations in immune-related adverse events of checkpoint inhibitorsShoiab Bukhari, Brian S Henick, Robert J Winchester, et al.
Pageof 1